Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$18.27 USD
-0.04 (-0.22%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.33 +0.06 (0.33%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.42 | 12.60% |
Earnings Summary
For their last quarter, Silence Therapeutics (SLN) reported earnings of -$0.42 per share, missing the Zacks Consensus Estimate of -$0.32 per share. This reflects a negative earnings surprise of 31.25%. Look out for SLN's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for SLN
Silence Therapeutics (SLN) Surges 5.7%: Is This an Indication of Further Gains?
SLN: What are Zacks experts saying now?
Zacks Private Portfolio Services